Evaluating safety and QoL [quality of life] in patients treated with etanercept: an open multicenter study
Phase of Trial: Phase IV
Latest Information Update: 23 Jun 2009
At a glance
- Drugs Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Wyeth
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2009 Actual end date (1 Apr 2006) added as reported by ClinicalTrials.gov.
- 06 Nov 2006 New trial record.